Roy Elias
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
-
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 23
-
- Renal and related cancers 9
- Histone Deacetylase Inhibitors Research 5
- Co-authors
- James Brugarolas (19 shared papers)Alana Christie (9 shared papers)Hans J. Hammers (9 shared papers)Nirmish Singla (14 shared papers)Payal Kapur (9 shared papers)Raquibul Hannan (4 shared papers)Qing Zhang (2 shared papers)Timothy J. Yeatman (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Blood (5 papers)Urologic Oncology Seminars and Original Investigations (3 papers)Clinical Genitourinary Cancer (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesRussiaAustria
In The Last Decade
Roy Elias
38 papers receiving 408 citations
Peers
Comparison fields: 5 of 57
- Oncology 191
- Pulmonary and Respiratory Medicine 141
- Cancer Research 62
- Immunology 56
- Hematology 28
Countries citing papers authored by Roy Elias
This map shows the geographic impact of Roy Elias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Elias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Elias more than expected).
Fields of papers citing papers by Roy Elias
This network shows the impact of papers produced by Roy Elias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Elias. The network helps show where Roy Elias may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Elias, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 58 | |
| 2 | 2017 | 45 | |
| 3 | 2019 | 42 | |
| 4 | 2019 | 41 | |
| 5 | 2022 | 33 | |
| 6 | 2020 | 28 | |
| 7 | 2020 | 24 | |
| 8 | 2015 | 24 | |
| 9 | 2022 | 16 | |
| 10 | 2020 | 13 | |
| 11 | 2015 | 13 | |
| 12 | 2022 | 10 | |
| 13 | 2021 | 9 | |
| 14 | 2015 | 8 | |
| 15 | 2018 | 5 | |
| 16 | 2019 | 4 | |
| 17 | 2015 | 4 | |
| 18 | 2015 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2024 | 3 |
About Roy Elias
Roy Elias is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 40 papers that have together received 411 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (23 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer Genomics and Diagnostics (10 papers), Renal and related cancers (9 papers), Acute Myeloid Leukemia Research (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Multiple and Secondary Primary Cancers (4 papers). The work is most often cited by research in Oncology (191 citations), Pulmonary and Respiratory Medicine (141 citations), Cancer Research (62 citations), Immunology (56 citations) and Hematology (28 citations). Roy Elias has collaborated with scholars based in United States, Russia and Austria. Frequent co-authors include James Brugarolas, Alana Christie, Hans J. Hammers, Nirmish Singla, Payal Kapur, Raquibul Hannan, Qing Zhang, Timothy J. Yeatman, Victoria Bryant and Susan McCarthy. Their work appears in journals such as Journal of Clinical Oncology, Blood, Urologic Oncology Seminars and Original Investigations, Clinical Genitourinary Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.